AskTheDate.com
Back to calendar

Estrella Immunopharma, Inc. (ESLA) Earnings

ESLA reports earnings on Wednesday, September 2, 2026

earnings report
September 2, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.09
Actual EPS: $-0.05
EPS surprise: 40.48%
Company overview
Market Cap$31.8M
PriceUSD 0.74
EPS (TTM)-0.35
52-week high3.15
52-week low0.69
SectorHealth Technology
IndustryBiotechnology